Revenue - Newron Pharmaceuticals SpA (SIX:NWRN) - Alpha Spread

Newron Pharmaceuticals SpA
SIX:NWRN

Watchlist Manager
Newron Pharmaceuticals SpA Logo
Newron Pharmaceuticals SpA
SIX:NWRN
Watchlist
Price: 7.66 CHF -3.04%
Market Cap: 145.9m CHF
Have any thoughts about
Newron Pharmaceuticals SpA?
Write Note

Newron Pharmaceuticals SpA
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Newron Pharmaceuticals SpA
Revenue Peer Comparison

Comparables:
REC
P
PRL
FCM
SHE

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Newron Pharmaceuticals SpA
SIX:NWRN
Revenue
€9.1m
CAGR 3-Years
20%
CAGR 5-Years
18%
CAGR 10-Years
N/A
Recordati Industria Chimica e Farmaceutica SpA
MIL:REC
Revenue
€2.2B
CAGR 3-Years
15%
CAGR 5-Years
10%
CAGR 10-Years
9%
P
Pierrel SpA
MIL:PRL
Revenue
€33m
CAGR 3-Years
14%
CAGR 5-Years
11%
CAGR 10-Years
-1%
Friulchem SpA
MIL:FCM
Revenue
€26.7m
CAGR 3-Years
17%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Shedir Pharma Srl Unipersonale
MIL:SHE
Revenue
€59.4m
CAGR 3-Years
11%
CAGR 5-Years
5%
CAGR 10-Years
N/A

See Also

What is Newron Pharmaceuticals SpA's Revenue?
Revenue
9.1m EUR

Based on the financial report for Dec 31, 2023, Newron Pharmaceuticals SpA's Revenue amounts to 9.1m EUR.

What is Newron Pharmaceuticals SpA's Revenue growth rate?
Revenue CAGR 5Y
18%

Over the last year, the Revenue growth was 49%. The average annual Revenue growth rates for Newron Pharmaceuticals SpA have been 20% over the past three years , 18% over the past five years .

Back to Top